|
CLEC2D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.025790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.683960E-01 |
| Normal-vs-Stage2 |
7.153000E-04 |
| Normal-vs-Stage3 |
7.949600E-02 |
| Normal-vs-Stage4 |
5.462400E-01 |
| Stage1-vs-Stage2 |
1.96649999950615E-07 |
| Stage1-vs-Stage3 |
2.352000E-01 |
| Stage1-vs-Stage4 |
1.921010E-01 |
| Stage2-vs-Stage3 |
5.82329999999631E-05 |
| Stage2-vs-Stage4 |
4.91660000001559E-06 |
| Stage3-vs-Stage4 |
6.194000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.478160E-01 |
| Normal-vs-AfricanAmerican |
9.916200E-02 |
| Normal-vs-Asian |
4.113600E-01 |
| Caucasian-vs-AfricanAmerican |
4.994200E-01 |
| Caucasian-vs-Asian |
2.813200E-01 |
| AfricanAmerican-vs-Asian |
1.710590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.614600E-01 |
| Normal-vs-Female |
9.049800E-02 |
| Male-vs-Female |
4.755200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.584800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.210300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.146300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.306200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.693600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.188200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.250800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.476200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.786600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.580800E-01 |
| Classical-VS-Follicular |
2.40819586494467E-11 |
| Classical-VS-Other |
6.525000E-01 |
| Classical-VS-Normal |
3.128800E-01 |
| Tall-VS-Follicular |
1.72853000000028E-05 |
| Tall-VS-Other |
5.782800E-01 |
| Tall-VS-Normal |
3.676200E-01 |
| Follicular-VS-Other |
5.455600E-02 |
| Follicular-VS-Normal |
7.045700E-04 |
| Other-VS-Normal |
2.326800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.632400E-02 |
| Normal-vs-N1 |
2.261400E-01 |
| N0-vs-N1 |
4.393700E-02 |
|
|
